Palliative Care for Patients With Liver Cirrhosis
Launched by ESBJERG HOSPITAL - UNIVERSITY HOSPITAL OF SOUTHERN DENMARK · Jun 22, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Liver cirrhosis of any etiology (diagnosed clinically, by imaging or histological features) as predominant chronic illness
- • 2. 2 or more items checked on the Supportive and Palliative Care Indicators Tool (SPICT™, appendix)
- • 3. Expressed desire for palliative support from the patient and relatives
- • 4. Ability to give informed consent
- Exclusion Criteria:
- • 1. Inability to give informed consent
- • 2. Age \< 18 years
- • 3. Ongoing contact with specialized palliative care teams or hospice
- • 4. Other chronic life-threatening illness than liver cirrhosis is more likely to become the cause of death within 1-2 years.
About Esbjerg Hospital University Hospital Of Southern Denmark
Esbjerg Hospital, part of the University Hospital of Southern Denmark, is a leading clinical research institution dedicated to advancing healthcare through innovative research and comprehensive patient care. With a focus on multidisciplinary collaboration and state-of-the-art facilities, the hospital conducts a wide range of clinical trials aimed at improving treatment outcomes and enhancing patient quality of life. Its commitment to scientific excellence and ethical standards positions Esbjerg Hospital as a pivotal contributor to the advancement of medical knowledge and the development of new therapies in southern Denmark and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Esbjerg, , Denmark
Patients applied
Trial Officials
Mette M Lauridsen
Principal Investigator
Head of Liver Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials